News Release

New insights into lanthanide-doped photon conversion nanoparticles advance biomedical imaging and diagnostics

Comprehensive review highlights recent strategies to enhance upconversion efficiency, improve biosafety, and enable clinical translation of lanthanide nanoprobes

Peer-Reviewed Publication

Chinese Society for Optical Engineering

Researchers at Harbin Institute of Technology and collaborating institutions have released a comprehensive review highlighting recent progress in lanthanide-doped photon conversion nanoparticles (LnNPs), a versatile class of luminescent nanomaterials with wide-ranging biomedical applications. Published in PhotoniX Life, the review emphasizes advances in enhancing upconversion and downconversion efficiency, improving biosafety, and exploring strategies to overcome regulatory barriers for clinical use.

LnNPs exhibit sharp emission bands, long luminescence lifetimes, and excellent photostability, enabling high-contrast imaging with minimal background interference. The review details diverse synthetic strategies, including thermal decomposition, hydrothermal, room-temperature, and green biosynthesis methods, highlighting innovations that produce uniform, high-brightness nanocrystals suitable for in vivo applications. Core-shell designs, ion-doping, and crystal-field engineering are discussed as approaches to optimize optical performance and multiplexed imaging capability.

Despite their promise, the clinical translation of LnNPs remains constrained by challenges such as low absorption cross-sections, potential toxicity, and lack of FDA approval. The authors propose integrating LnNPs with existing medical instrumentation, employing environmentally friendly synthesis routes, and addressing long-term biosafety to accelerate adoption in diagnostics, imaging, and theranostic therapy.

“Lanthanide-doped nanoparticles offer unique optical advantages for biomedical applications, but clinical deployment requires addressing biosafety and regulatory challenges,” said Guanying Chen, corresponding author. “Our review outlines strategies that could bridge the gap from laboratory research to real-world medical use.”

The review serves as a roadmap for scientists and engineers aiming to harness the full potential of LnNPs in biology and medicine, offering guidance on synthesis, functionalization, and clinical translation.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.